$486 Million is the total value of SECTOR GAMMA AS's 25 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 29.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
LLY | Buy | LILLY ELI & CO | $55,548,000 | +62.2% | 771,390 | +89.8% | 11.43% | +29.9% |
BAX | Buy | BAXTER INTL INC | $50,028,000 | +39.9% | 1,217,830 | +29.9% | 10.30% | +12.0% |
BSX | Buy | BOSTON SCIENTIFIC CORP | $33,223,000 | +28.4% | 1,766,250 | +25.9% | 6.84% | +2.8% |
IRWD | Buy | IRONWOOD PHARMACEUTICALS INC | $27,205,000 | +18.9% | 2,486,757 | +25.9% | 5.60% | -4.8% |
STJ | Buy | ST JUDE MED INC | $26,043,000 | +268.0% | 473,514 | +313.3% | 5.36% | +194.8% |
PKI | Buy | PERKINELMER INC | $24,682,000 | +13.3% | 499,030 | +22.7% | 5.08% | -9.3% |
SHPG | New | SHIRE PLCsponsored adr | $23,323,000 | – | 135,680 | +100.0% | 4.80% | – |
MRK | New | MERCK & CO INC NEW | $22,971,000 | – | 434,160 | +100.0% | 4.73% | – |
BIIB | Buy | BIOGEN IDEC INC | $21,323,000 | -7.6% | 81,910 | +8.8% | 4.39% | -26.0% |
BMY | Buy | BRISTOL MYERS SQUIBB CO | $21,000,000 | +43.7% | 328,740 | +54.7% | 4.32% | +15.1% |
IART | Buy | INTEGRA LIFESCIENCES HLDGS C | $20,306,000 | +21.1% | 301,457 | +21.8% | 4.18% | -3.0% |
BIO | Buy | BIO RAD LABS INCcl a | $18,151,000 | +9.2% | 132,764 | +10.8% | 3.74% | -12.5% |
MDVN | Buy | MEDIVATION INC | $17,745,000 | +120.7% | 385,923 | +132.0% | 3.65% | +76.8% |
VRTX | Buy | VERTEX PHARMACEUTICALS INC | $16,553,000 | +12.8% | 208,243 | +78.5% | 3.41% | -9.7% |
PDCO | New | PATTERSON COMPANIES INC | $15,414,000 | – | 331,264 | +100.0% | 3.17% | – |
BXLT | Sell | BAXALTA INC | $14,395,000 | -59.7% | 356,310 | -61.1% | 2.96% | -67.8% |
MCK | Buy | MCKESSON CORP | $13,939,000 | +118.8% | 88,640 | +174.4% | 2.87% | +75.3% |
CI | Buy | CIGNA CORPORATION | $13,670,000 | +3.8% | 99,610 | +10.7% | 2.81% | -16.9% |
MASI | Buy | MASIMO CORP | $13,324,000 | +11.5% | 318,463 | +10.6% | 2.74% | -10.7% |
OMI | Sell | OWENS & MINOR INC NEW | $8,943,000 | -25.6% | 221,252 | -33.8% | 1.84% | -40.5% |
WCG | Sell | WELLCARE HEALTH PLANS INC | $8,544,000 | +9.4% | 92,115 | -7.8% | 1.76% | -12.4% |
MNTA | Buy | MOMENTA PHARMACEUTICALS INC | $7,210,000 | +14.4% | 780,313 | +83.8% | 1.48% | -8.3% |
UTHR | New | UNITED THERAPEUTICS CORP DEL | $6,709,000 | – | 60,204 | +100.0% | 1.38% | – |
THC | Sell | TENET HEALTHCARE CORP | $5,164,000 | -34.0% | 178,490 | -30.8% | 1.06% | -47.1% |
SPPI | Buy | SPECTRUM PHARMACEUTICALS INC | $506,000 | +10.5% | 79,600 | +4.7% | 0.10% | -11.9% |
CYH | Exit | COMMUNITY HEALTH SYS INC | $0 | – | -183,970 | -100.0% | -1.25% | – |
CAH | Exit | CARDINAL HEALTH INC | $0 | – | -113,430 | -100.0% | -2.60% | – |
JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -302,930 | -100.0% | -8.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
PERKINELMER INC | 33 | Q2 2021 | 6.3% |
BIOGEN INC | 30 | Q3 2023 | 7.6% |
ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-05 |
13F-HR | 2023-11-06 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-12 |
13F-HR/A | 2023-02-08 |
13F-HR | 2023-02-07 |
13F-HR | 2022-11-09 |
13F-HR | 2022-08-05 |
13F-HR | 2022-05-06 |
13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.